Articles in section Mergers & Acquisitions
<< Licensing | 617 articles | Opinion & Analysis >> |
Pages 1 2 3 4 5 .. 62 | Next >> |
-
Ipsen Acquires Epizyme to Broaden its Oncology Portfolio
-
Vertex Buys ViaCyte for Diabetes Stem Cell Treatment
-
AstraZeneca Acquires TeneoTwo in US$1.27 B Deal
-
Galapagos Acquires CellPoint and AboundBio for Next-Generation Cell Therapies
-
Bristol Myers Squibb Buys Turning Point for US$4.1 B
-
GlaxoSmithKline Acquires Affinivax for US$3.3 B
-
Pfizer Buys Biohaven for US$11.6 B
-
Caladrius and Cend Merge to Become Lisata Therapeutics
-
Regeneron Bolsters I-O Portfolio with US$250 M Checkmate Acquisition
-
GlaxoSmithKline Gets Momelotinib with US$1.9 B Sierra Oncology Buyout